Clinical Study

Serum Immunoglobulin Free Light Chain Assessment in IgG4-Related Disease

Table 1

Patients’ characteristics.

Age,
gender
IgG4-RD organ
involvement
FLC
mg/L
FLC
mg/L
/ ratioGFRDisease
status

1*84, MRPF, mesenteric IPT, lung, LN59.8529.632.02A
271, MKidney, LN, pancreas, biliary tree, prostate41.9729.311.4339A
363, MRPF, AIP, sclerosing cholangitis, sialadenitis, renal IPT, LN, periaortitis, pleura/lung49.824.542.02A
471, MRPF, aortitis, dacryoadenitis, sialadenitis, LN27.5547.20.58A
5*59, MRPF, aortitis, carotidal and iliac arteritis, LN, hypophysitis30.489.483.21A
6*74, MAIP, orbital IPT, sialadenitis, sclerosing cholangitis, sclerosing cholecystitis, TIN12.4412.31.01A
775, MAIP, LN, TIN, sialadenitis, pleura/lung26105115.1112A
863, MMeningeal IPT20.918.41.14A
967, MPeriaortitis20.3912.461.63A
1065, MAIP61.85650.95A
1158, FPulmonary IPT20.1416.191.24A
1227, MAIP, sclerosing cholangitis, LN219.6233.246.6A
1380, MSialadenitis, TIN, LN, lung15013124.846A
1462, MParotid IPT, LN13.8131.06A
1576, MRPF, LN46.222.12.09A
1684, MTIN, LN, PAI, RPF, sialadenitis97.379.421.2267NA
Mean**315.7 77.06
Median**41.97 24.54 1.63
IQR**(20.39–61.85)(13–47.2)(1.06–3.2)

Values in bold are normal values.
Patients from which samples were analyzed two times (in active and nonactive disease). Given values in the table are values during active disease, **given values for mean, median and IQR are calculated with values obtained in patients with active disease (patient no. 16 is excluded). AIP: autoimmune pancreatitis; IPT: inflammatory pseudotumor: LN: lymph nodes; RPF: retroperitoneal fibrosis; TIN: tubulointerstitial nephritis; GFR: glomerular filtration rate (mL/min/1.73 m2). Disease status: A: active, NA: nonactive.